SPR Therapeutics Receives $2,200,000 Series A Round

  • Feed Type
  • Date
    1/24/2012
  • Company Name
    SPR Therapeutics
  • Mailing Address
    22901 Millcreek Blvd Cleveland, OH 44122
  • Company Description
    SPR Therapeutics is a medical device company that is commercializing pain treatments utilizing its proprietary peripheral nerve stimulation (PNS) products. We are developing a pipeline of neurostimulation pain therapies that will exploit the same physiologic mechanism of action, proprietary technology, and clinical approach.
  • Website
    http://www.sprtherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,200,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    SPR has also applied for the CE Mark, which signifies European regulatory approval, and expects to receive the designation within a few months. SPR expects to soon begin a pivotal clinical trial aimed at obtaining U.S. Food and Drug Administration clearance.
  • M&A Terms
  • Venture Investor
    NDI Medical
  • Venture Investor
    Undisclosed

Trending on Xconomy